Vascular dysfunction in retinopathy-An emerging role for arginase

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Retinal neovascularization is a leading cause of visual disability. Retinal diseases involving neovascularization all follow the same progression, beginning with vascular inflammatory reactions and injury of the vascular endothelium and ending with neovascularization, fibrosis and retinal detachment. Understanding the mechanisms underlying this process is critical for its prevention and treatment. Research using retinopathy models has revealed that the NOX2 NADPH oxidase has a key role in inducing production of reactive oxygen species and angiogenic cytokines and causing vascular inflammatory reactions and neovascularization. This prospective review addresses the potential role of the urea/ornithine pathway enzyme arginase in this process. Studies of peripheral vessels isolated from diabetic animals have shown that increased arginase activity causes vascular endothelial cell dysfunction by decreasing availability of l-arginine to endothelial cell nitric oxide synthase which decreases nitric oxide bioavailability and increases oxidative stress. Increasing arginase activity also increases formation of polyamines and proline, which can induce cell growth and fibrosis. Studies in models of retinopathy show that increases in oxidative stress and signs of vascular inflammation are correlated with increases in arginase activity and arginase 1 expression and that decreasing arginase expression or inhibiting its activity blocks these effects. Furthermore, the induction of arginase during retinopathy is blocked by knocking out NOX2 or inhibiting NADPH oxidase activity. These observations suggest that NADPH oxidase-induced activation of the arginase pathway has a key role in causing retinal vascular dysfunction during retinopathy. Limiting the actions of arginase could provide a new strategy for treating this potentially blinding condition.

Original languageEnglish (US)
Pages (from-to)303-309
Number of pages7
JournalBrain Research Bulletin
Volume81
Issue number2-3
DOIs
StatePublished - Feb 15 2010

Fingerprint

Arginase
Blood Vessels
NADPH Oxidase
Oxidative Stress
Fibrosis
Endothelial Cells
Retinal Neovascularization
Retinal Diseases
Retinal Vessels
Ornithine
Nitric Oxide Synthase Type III
Vascular Endothelium
Polyamines
Retinal Detachment
Proline
Biological Availability
Arginine
Urea
Reactive Oxygen Species
Nitric Oxide

Keywords

  • Arginase
  • Endothelial cell dysfunction
  • Nitric oxide synthase
  • Oxidative stress
  • Retinopathy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Vascular dysfunction in retinopathy-An emerging role for arginase. / Caldwell, Ruth B; Zhang, Wenbo; Romero Lucas, Maritza Josefina; Caldwell, Robert William.

In: Brain Research Bulletin, Vol. 81, No. 2-3, 15.02.2010, p. 303-309.

Research output: Contribution to journalReview article

@article{5bae9a3e191e4ca9939f48e6e37d52f4,
title = "Vascular dysfunction in retinopathy-An emerging role for arginase",
abstract = "Retinal neovascularization is a leading cause of visual disability. Retinal diseases involving neovascularization all follow the same progression, beginning with vascular inflammatory reactions and injury of the vascular endothelium and ending with neovascularization, fibrosis and retinal detachment. Understanding the mechanisms underlying this process is critical for its prevention and treatment. Research using retinopathy models has revealed that the NOX2 NADPH oxidase has a key role in inducing production of reactive oxygen species and angiogenic cytokines and causing vascular inflammatory reactions and neovascularization. This prospective review addresses the potential role of the urea/ornithine pathway enzyme arginase in this process. Studies of peripheral vessels isolated from diabetic animals have shown that increased arginase activity causes vascular endothelial cell dysfunction by decreasing availability of l-arginine to endothelial cell nitric oxide synthase which decreases nitric oxide bioavailability and increases oxidative stress. Increasing arginase activity also increases formation of polyamines and proline, which can induce cell growth and fibrosis. Studies in models of retinopathy show that increases in oxidative stress and signs of vascular inflammation are correlated with increases in arginase activity and arginase 1 expression and that decreasing arginase expression or inhibiting its activity blocks these effects. Furthermore, the induction of arginase during retinopathy is blocked by knocking out NOX2 or inhibiting NADPH oxidase activity. These observations suggest that NADPH oxidase-induced activation of the arginase pathway has a key role in causing retinal vascular dysfunction during retinopathy. Limiting the actions of arginase could provide a new strategy for treating this potentially blinding condition.",
keywords = "Arginase, Endothelial cell dysfunction, Nitric oxide synthase, Oxidative stress, Retinopathy",
author = "Caldwell, {Ruth B} and Wenbo Zhang and {Romero Lucas}, {Maritza Josefina} and Caldwell, {Robert William}",
year = "2010",
month = "2",
day = "15",
doi = "10.1016/j.brainresbull.2009.08.025",
language = "English (US)",
volume = "81",
pages = "303--309",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "2-3",

}

TY - JOUR

T1 - Vascular dysfunction in retinopathy-An emerging role for arginase

AU - Caldwell, Ruth B

AU - Zhang, Wenbo

AU - Romero Lucas, Maritza Josefina

AU - Caldwell, Robert William

PY - 2010/2/15

Y1 - 2010/2/15

N2 - Retinal neovascularization is a leading cause of visual disability. Retinal diseases involving neovascularization all follow the same progression, beginning with vascular inflammatory reactions and injury of the vascular endothelium and ending with neovascularization, fibrosis and retinal detachment. Understanding the mechanisms underlying this process is critical for its prevention and treatment. Research using retinopathy models has revealed that the NOX2 NADPH oxidase has a key role in inducing production of reactive oxygen species and angiogenic cytokines and causing vascular inflammatory reactions and neovascularization. This prospective review addresses the potential role of the urea/ornithine pathway enzyme arginase in this process. Studies of peripheral vessels isolated from diabetic animals have shown that increased arginase activity causes vascular endothelial cell dysfunction by decreasing availability of l-arginine to endothelial cell nitric oxide synthase which decreases nitric oxide bioavailability and increases oxidative stress. Increasing arginase activity also increases formation of polyamines and proline, which can induce cell growth and fibrosis. Studies in models of retinopathy show that increases in oxidative stress and signs of vascular inflammation are correlated with increases in arginase activity and arginase 1 expression and that decreasing arginase expression or inhibiting its activity blocks these effects. Furthermore, the induction of arginase during retinopathy is blocked by knocking out NOX2 or inhibiting NADPH oxidase activity. These observations suggest that NADPH oxidase-induced activation of the arginase pathway has a key role in causing retinal vascular dysfunction during retinopathy. Limiting the actions of arginase could provide a new strategy for treating this potentially blinding condition.

AB - Retinal neovascularization is a leading cause of visual disability. Retinal diseases involving neovascularization all follow the same progression, beginning with vascular inflammatory reactions and injury of the vascular endothelium and ending with neovascularization, fibrosis and retinal detachment. Understanding the mechanisms underlying this process is critical for its prevention and treatment. Research using retinopathy models has revealed that the NOX2 NADPH oxidase has a key role in inducing production of reactive oxygen species and angiogenic cytokines and causing vascular inflammatory reactions and neovascularization. This prospective review addresses the potential role of the urea/ornithine pathway enzyme arginase in this process. Studies of peripheral vessels isolated from diabetic animals have shown that increased arginase activity causes vascular endothelial cell dysfunction by decreasing availability of l-arginine to endothelial cell nitric oxide synthase which decreases nitric oxide bioavailability and increases oxidative stress. Increasing arginase activity also increases formation of polyamines and proline, which can induce cell growth and fibrosis. Studies in models of retinopathy show that increases in oxidative stress and signs of vascular inflammation are correlated with increases in arginase activity and arginase 1 expression and that decreasing arginase expression or inhibiting its activity blocks these effects. Furthermore, the induction of arginase during retinopathy is blocked by knocking out NOX2 or inhibiting NADPH oxidase activity. These observations suggest that NADPH oxidase-induced activation of the arginase pathway has a key role in causing retinal vascular dysfunction during retinopathy. Limiting the actions of arginase could provide a new strategy for treating this potentially blinding condition.

KW - Arginase

KW - Endothelial cell dysfunction

KW - Nitric oxide synthase

KW - Oxidative stress

KW - Retinopathy

UR - http://www.scopus.com/inward/record.url?scp=73149090994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149090994&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2009.08.025

DO - 10.1016/j.brainresbull.2009.08.025

M3 - Review article

C2 - 19737603

AN - SCOPUS:73149090994

VL - 81

SP - 303

EP - 309

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 2-3

ER -